ABT-450

Cubist, Enanta and Vertex still await FDA approval decisions this year
Bizjournals.com
Fri, 12/19/14 - 04:11 pm
Cubist
Enanta
Vertex Pharmaceuticals
FDA
Zerbaxa
ABT-450
Kalydeco
AbbVie Hepatitis C Drug Cures 97% in Transplant Patients Study
Bloomberg
Tue, 11/11/14 - 09:55 am
AbbVie
hepatitis C
ombitasvir
ritonavir
dasabuvir
ABT-450
Enanta notes AbbVie granted FDA priority review for Hep C combo regimen
Yahoo/Fly on the Wall
Fri, 06/13/14 - 06:44 pm
AbbVie
Enanta Pharmaceuticals
FDA
hepatitis C
ABT-450
AbbVie Submits New Drug Application to U.S. FDA for its Investigational, All-Oral, Interferon-Free Therapy for the Treatment of Hepatitis C
Yahoo
Tue, 04/22/14 - 09:48 am
hepatitis C
FDA
Enanta Pharmaceuticals
ABT-450
AbbVie
Today's Biggest Biotech Stories: Dendreon, AbbVie, and Omeros
Motley Fool
Tue, 03/4/14 - 12:31 pm
Dendreon
AbbVie
Omeros
Provenge
prostate cancer
ABT-450
hepatitis C
OMS721
AbbVie Hepatitis C Combo Cures Almost All in Late Study
Bloomberg
Mon, 03/3/14 - 06:46 pm
AbbVie
hepatitis C
ABT-450
ABT-267
ABT-333
Gilead Sciences
Bristol-Myers Squibb
AbbVie's Challenge to Gilead in Hepatitis C Therapies
Motley Fool
Tue, 02/4/14 - 07:00 pm
AbbVie
Gilead Sciences
Sovaldi
hepatitis C
Enanta Pharmaceuticals
ABT-450
This Week in Biotech: Let's Get Clinical!
Motley Fool
Sun, 02/2/14 - 11:30 am
AbbVie
Enanta Pharmaceuticals
ABT-450
hepatitis C
Medivation
Xtandi
prostate cancer
Astellas
Geron
imetelstat
PSMA-ADC
Progenics Pharmaceuticals
Idenix
AbbVie Headed to FDA, Clash With Gilead Set
Motley Fool
Sat, 02/1/14 - 10:49 am
AbbVie
Gilead Sciences
ABT-450
hepatitis
hepatitis C
Enanta Pharmaceuticals
Enanta Joins Big Leagues With Hepatitis C Drug
Investors.com
Wed, 01/8/14 - 08:07 am
Enanta
hepatitis C
AbbVie
ABT-450
protease inhibitors
Why Enanta Pharmaceuticals Shares Sank Like a Stone
Motley Fool
Thu, 12/19/13 - 08:08 am
Enanta
Sovaldi
Gilead Sciences
hepatitis C
ABT-450
AbbVie
AbbVie's second PhIII hep C study confirms cocktail's promise
Fierce Biotech
Tue, 12/10/13 - 10:49 am
hepatitis C
Enanta Pharmaceuticals
ABT-450
AbbVie
Gilead And AbbVie Battle For Top Spot In $20 Billion Hepatitis Drug Market
Seeking Alpha
Sun, 11/24/13 - 12:24 pm
Gilead Sciences
AbbVie
hepatitis
hepatitis C
sofosbuvir
ABT-450
ABT-333
ABT-267
Don't Crown the Hepatitis C Drug Winner Just Yet
Motley Fool
Tue, 11/19/13 - 07:35 am
hepatitis C
Gilead Sciences
ABT-333
Ribavirin
ABT-450
ritonavir
ABT-267
AbbVie
New GT-1b Data from ABT-450 Containing Regimen Being Presented at The Liver Meeting
Yahoo/BusinessWire
Sun, 11/3/13 - 12:08 pm
Enanta Pharmaceuticals
ABT-450
ABT-267
hepatitis
hepatitis C
AbbVie hepatitis C drugs knock out virus at 8 weeks
Reuters
Tue, 04/23/13 - 07:50 am
hepatitis C
AbbVie
ABT-450
ABT-333
ABT-267
Another Reason To Be Long AbbVie When Abbott Splits In Two
Seeking Alpha
Tue, 10/16/12 - 10:42 am
AbbVie
Abbott Labs
ABT-450
Abbott Hep C Therapy Achieves Almost-Perfect Cure Rate
TheStreet.com
Mon, 10/15/12 - 11:37 am
Abbott Labs
hepatitis C
ABT-450
ABT-267
ABT-333
Gilead
Abbott Presents Positive Results From Phase 2 "Pilot" Study Of An Interferon-Free Combination Regimen For The Treatment Of Hepatitis C
Pharmaceutical Online
Sat, 04/21/12 - 01:03 pm
Abbott Laboratories
ABT-072
ABT-450
hepatitis C
5 Biotech Stocks That Could Soar On New Hepatitis C Drugs
Seeking Alpha
Sat, 04/21/12 - 12:17 pm
Vertex
Incivek
ABT-072
ABT-450
Abbott Laboratories
Achillion
ACH-1625
ACH-2684
ACH-2928
ACH-3102
TMC435
JNJ
GSK
hepatitis C

Pages